A new way of collaboration in the field of anti-infectives

Often, it is not the lack of groundbreaking ideas that prevents the development of novel, innovative anti-infective drugs. Rather, a lack of funding, development and business experience limits resources for start-ups and scientific groups, discouraging the development of new therapeutic options. AiCuris strongly believes that there is a need to encourage the development of more early projects. Therefore, we are constantly searching for novel technologies and creative approaches to develop more effective treatments against infectious diseases with high medical needs.

Converting Great ideas into Reality

To promote early ideas that might lead to the next resistant breaking anti-infective, AiCuris has launched the AiCubator, an innovative corporate incubator that provides first-hand and long-term support (up to 3 years) for such research projects from a leader in anti-infective drug development. 



Get more information


 projects Wanted

  • Academic research groups or early start-ups working on drug discovery projects for the treatment of viral infections in immunocompromised patients
  • Indications:
    • BK virus
    • Adenovirus
    • Other viruses

Minimal requirements

  • Non-cytotoxic hits or leads with in vitro activity
  • Academic group or early start-up company



For additional questions and submission of applications please contact us